Steven Lefkowitz joins CorMedix board
This article was originally published in Scrip
Executive Summary
CorMedix, a pharmaceutical company developing and commercialising therapeutic products for the prevention and treatment of cardio-renal disease, has appointed Steven Lefkowitz to its board of directors. Mr Lefkowitz is currently president of Wade Capital Corporation, a company he founded.